检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Phase 2 study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Final analysis from EMPOWER-CSCC-1 Groups 1, 2, and 3

Michael Migden,Chrysalyne Schmults,Nikhil Khushalani,Alexander Guminski, Anne Lynn Chang,Karl Lewis,George Ansstas,Samantha Bowyer,Brett Hughes,Dirk Schadendorf,Badri Modi,Lara Dunn,Lukas Flatz,Axel Hauschild,Suk-Young Yoo, Jocelyn Booth,Frank Seebach,Israel Lowy,Matthew Fury,Danny Rischin

SKIN The Journal of Cutaneous Medicine（2023）

引用 0|浏览21
暂无评分
关键词
cemiplimab,carcinoma,empower-cscc
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要